These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 10408865

  • 1. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
    Baretton GB, Klenk U, Diebold J, Schmeller N, Löhrs U.
    Br J Cancer; 1999 May; 80(3-4):546-55. PubMed ID: 10408865
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
    Baretton GB, Diebold J, Christoforis G, Vogt M, Müller C, Dopfer K, Schneiderbanger K, Schmidt M, Löhrs U.
    Cancer; 1996 Jan 15; 77(2):255-64. PubMed ID: 8625232
    [Abstract] [Full Text] [Related]

  • 3. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K, Kosma VM.
    Br J Cancer; 1999 Aug 15; 80(12):2001-7. PubMed ID: 10471053
    [Abstract] [Full Text] [Related]

  • 4. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
    Zlotta AR, Noel JC, Fayt I, Drowart A, Van Vooren JP, Huygen K, Simon J, Schulman CC.
    J Urol; 1999 Mar 15; 161(3):792-8. PubMed ID: 10022686
    [Abstract] [Full Text] [Related]

  • 5. The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer.
    Fizazi K, Martinez LA, Sikes CR, Johnston DA, Stephens LC, McDonnell TJ, Logothetis CJ, Trapman J, Pisters LL, Ordoñez NG, Troncoso P, Navone NM.
    Clin Cancer Res; 2002 Mar 15; 8(3):775-81. PubMed ID: 11895908
    [Abstract] [Full Text] [Related]

  • 6. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
    Shi Y, Chatterjee SJ, Brands FH, Shi SR, Pootrakul L, Taylor CR, Datar R, Cote RJ.
    BJU Int; 2006 Jan 15; 97(1):170-8. PubMed ID: 16336351
    [Abstract] [Full Text] [Related]

  • 7. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Michael M, Stavropoulos NE, Kitsiou E, Hastazeris K, Salmas M, Stefanaki S, Agnantis NJ.
    Urol Int; 2004 Jan 15; 73(1):65-73. PubMed ID: 15263796
    [Abstract] [Full Text] [Related]

  • 8. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G, Antonaci A, Bosco D, Nardoni S, Melis M.
    J Exp Clin Cancer Res; 1999 Sep 15; 18(3):363-7. PubMed ID: 10606183
    [Abstract] [Full Text] [Related]

  • 9. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
    Rau B, Sturm I, Lage H, Berger S, Schneider U, Hauptmann S, Wust P, Riess H, Schlag PM, Dörken B, Daniel PT.
    J Clin Oncol; 2003 Sep 15; 21(18):3391-401. PubMed ID: 12885834
    [Abstract] [Full Text] [Related]

  • 10. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov 15; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of apoptosis in synovial sarcoma: correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins.
    Kawauchi S, Fukuda T, Oda Y, Saito T, Oga A, Takeshita M, Yokoyama K, Chuman H, Iwamoto Y, Sasaki K, Tsuneyoshi M.
    Mod Pathol; 2000 Jul 15; 13(7):755-65. PubMed ID: 10912935
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N.
    Hepatogastroenterology; 1999 Jul 15; 46(28):2648-53. PubMed ID: 10522058
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 Jul 15; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH.
    Liver Int; 2007 Aug 15; 27(6):772-81. PubMed ID: 17617120
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):1190-7. PubMed ID: 10741751
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors in prostate cancer.
    Stattin P.
    Scand J Urol Nephrol Suppl; 1997 Mar 15; 185():1-46. PubMed ID: 9249905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.